ReviewFrontline gastroenterology2021
Ischaemic colitis: practical challenges and evidence-based recommendations for management.
Review in Frontline gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 33 citations in OpenAlex.
- Relative colon wall attenuation - distinguishing ischemia from other colon wall changes.BMC medical imaging · 2026Article
- Venous congestive ischemic colitis following left hemicolectomy: A rare case of superior rectal vein occlusion.Radiology case reports · 2026Article
- Abdominal symptoms of invasive meningococcal disease are associated with the induction of plasminogen activator inhibitor-1 in omental adipocytes.BMC infectious diseases · 2026Article
- Patient characteristics, antibiotic use, and in-hospital outcomes in patients with ischaemic colitis: A nationwide retrospective cohort study.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2026Article
- Amphetamine-Induced Ischemic Colitis: A Case Report.Cureus · 2025Article
- Article
- Assessing the association between drug use and ischaemic colitis: a retrospective pharmacovigilance study using FDA Adverse Event data.BMJ open · 2025Article
- Management of gastrointestinal bleed in the intensive care setting, an updated literature review.World journal of critical care medicine · 2025Review
- Semaglutide-Associated Ischemic Colitis in a Patient Without Traditional Risk Factors: A Case Report.Cureus · 2025Article
- Oral bowel cleansers and ischemic colitis risk: A real-world disproportionality analysis.PloS one · 2025Article
- Nonsteroidal Anti-Inflammatory Drug-Induced Granulomatous Colitis: A Case Report and Literature Review of a Vanishing Colonic Mass Mimicking Malignancy.Case reports in gastrointestinal medicine · 2025Article
- Risk Factors Associated with Progression to Surgery in Patients with Ischemic Colitis.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2024Observational
- Article
- Prevalence and predictive value of sarcopenia in hospitalized patients with ischemic colitis.Scientific reports · 2024Article
- Ischaemic Colitis from an Unusual Cause: Oral Contraceptives.European journal of case reports in internal medicine · 2024Article
- Contrast-induced ischemic colitis following coronary angiography: A case report.World journal of clinical cases · 2023Article
- HELLP syndrome complicated by ischemic colitis: A case report.Clinical case reports · 2023Article
- A case report of transmural rectosigmoid ischemia in an elderly patient.International journal of surgery case reports · 2023Article
- [Computed tomography and magnetic resonance imaging of colonic diseases].Radiologie (Heidelberg, Germany) · 2023Review
- Ischemic Colitis Presented as Pseudomembranous Colitis: An Untypical Case from Vietnam.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ischaemic colitis (IC) is a common condition with rising incidence, and in severe cases a high mortality rate. Its presentation, severity and disease behaviour can vary widely, and there exists significant heterogeneity in treatment strategies and resultant outcomes. In this article we explore practical challenges in the management of IC, and where available make evidence-based recommendations for its management based on a comprehensive review of available literature. An optimal approach to initial management requires early recognition of the diagnosis followed by prompt and appropriate investigation. Ideally, this should involve the input of both gastroenterology and surgery. CT with intravenous contrast is the imaging modality of choice. It can support clinical diagnosis, define the severity and distribution of ischaemia, and has prognostic value. In all but fulminant cases, this should be followed (within 48 hours) by lower gastrointestinal endoscopy to reach the distal-most extent of the disease, providing endoscopic (and histological) confirmation. The mainstay of medical management is conservative/supportive treatment, with bowel rest, fluid resuscitation and antibiotics. Specific laboratory, radiological and endoscopic features are recognised to correlate with more severe disease, higher rates of surgical intervention and ultimately worse outcomes. These factors should be carefully considered when deciding on the need for and timing of surgical intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.